Company registration number 09928037 (England and Wales)
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
BALANCE SHEET
AS AT 30 DECEMBER 2025
30 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
55,805
77,903
Investments
5
400
400
56,205
78,303
Current assets
Debtors
7
26,318
27,594
Cash at bank and in hand
586
474
26,904
28,068
Creditors: amounts falling due within one year
8
(695,033)
(592,645)
Net current liabilities
(668,129)
(564,577)
Total assets less current liabilities
(611,924)
(486,274)
Creditors: amounts falling due after more than one year
9
(10,018)
(20,779)
Net liabilities
(621,942)
(507,053)
Capital and reserves
Called up share capital
400
400
Profit and loss reserves
(622,342)
(507,453)
Total equity
(621,942)
(507,053)
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 DECEMBER 2025
30 December 2025
- 2 -

For the financial year ended 30 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 16 September 2026 and are signed on its behalf by:
Dr N N Amso
Director
Company registration number 09928037 (England and Wales)
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Advanced Medical Simulation Online Limited is a private company limited by shares, company number 09928037, incorporated in England and Wales. The registered office is 62 Ely Road, Cardiff, Wales, CF5 2JG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

The directors acknowledge that the company's financial statements show net current liabilities at the balance sheet date. As such the directors have indicated that they will continue to support the company for a period of at least twelve months from the date the financial statements are approved.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Leasehold
7 years straight line
Plant and machinery
33% straight line / over life of lease
Fixtures, fittings & equipment
20% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.6
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price.

1.8
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

1.12
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
6
7
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2025
- 6 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 31 December 2024
116,033
62,745
178,778
Additions
864
5,761
6,625
At 30 December 2025
116,897
68,506
185,403
Depreciation
At 31 December 2024
55,564
45,311
100,875
Depreciation charged in the year
16,689
12,034
28,723
At 30 December 2025
72,253
57,345
129,598
Carrying amount
At 30 December 2025
44,644
11,161
55,805
At 30 December 2024
60,469
17,434
77,903
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
400
400
6
Subsidiaries

Details of the company's subsidiaries at 30 December 2024 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Medical and Educational Academy Limited
United Kingdom
Ordinary A and Ordinary B shares
100.00
AMSO Healthcare Limited
United Kingdom
Ordinary shares
100.00
The aggregate capital and reserves and the result for the year of the subsidiaries noted above was as follows:
Name of undertaking
Capital and Reserves
Profit/(Loss)
£
£
Medical and Educational Academy Limited
(47,899)
0
(28,428)
0
AMSO Healthcare Limited
182,615
69,581
ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2025
- 7 -
7
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
6,007
Other debtors
26,318
21,587
26,318
27,594
8
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
11,256
15,456
Trade creditors
-
0
5,351
Amounts owed to group undertakings
424,231
337,417
Taxation and social security
2,867
1,566
Other creditors
241,659
210,648
Accruals and deferred income
15,020
22,207
695,033
592,645

Obligations under finance leases are secured on the assets to which they relate.

9
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
7,518
9,079
Obligations under finance leases
-
0
4,200
Other borrowings
2,500
7,500
10,018
20,779

Obligations under finance leases are secured on the assets to which they relate.

ADVANCED MEDICAL SIMULATION ONLINE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 DECEMBER 2025
- 8 -
10
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
93,022
134,365
2025-12-302024-12-31falsefalsefalse16 September 2026CCH SoftwareCCH Accounts Production 2026.200No description of principal activityDr J L ScottDr N N Amso099280372024-12-312025-12-30099280372025-12-30099280372024-12-3009928037core:WithinOneYear2025-12-3009928037core:WithinOneYear2024-12-3009928037core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3009928037core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3009928037core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3009928037core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3009928037core:ShareCapital2025-12-3009928037core:ShareCapital2024-12-3009928037core:RetainedEarningsAccumulatedLosses2025-12-3009928037core:RetainedEarningsAccumulatedLosses2024-12-3009928037bus:Director22024-12-312025-12-3009928037core:LandBuildingscore:LongLeaseholdAssets2024-12-312025-12-3009928037core:PlantMachinery2024-12-312025-12-3009928037core:FurnitureFittings2024-12-312025-12-30099280372024-01-012024-12-3009928037core:LandBuildings2024-12-3009928037core:OtherPropertyPlantEquipment2024-12-30099280372024-12-3009928037core:LandBuildings2025-12-3009928037core:OtherPropertyPlantEquipment2025-12-3009928037core:LandBuildings2024-12-312025-12-3009928037core:OtherPropertyPlantEquipment2024-12-312025-12-3009928037core:LandBuildings2024-12-3009928037core:OtherPropertyPlantEquipment2024-12-3009928037core:Subsidiary12024-12-312025-12-3009928037core:Subsidiary22024-12-312025-12-3009928037core:Subsidiary112024-12-312025-12-3009928037core:Subsidiary222024-12-312025-12-3009928037core:Subsidiary12025-12-3009928037core:Subsidiary22025-12-3009928037core:CurrentFinancialInstruments2025-12-3009928037core:CurrentFinancialInstruments2024-12-3009928037bus:PrivateLimitedCompanyLtd2024-12-312025-12-3009928037bus:SmallCompaniesRegimeForAccounts2024-12-312025-12-3009928037bus:FRS1022024-12-312025-12-3009928037bus:AuditExemptWithAccountantsReport2024-12-312025-12-3009928037bus:Director12024-12-312025-12-3009928037bus:FullAccounts2024-12-312025-12-30xbrli:purexbrli:sharesiso4217:GBP